Eterna Therapeutics
ERNA
#9228
Rank
โ‚ฌ52.24 M
Marketcap
1,02ย โ‚ฌ
Share price
-5.26%
Change (1 day)
-5.44%
Change (1 year)

Eterna Therapeutics (ERNA) - P/B ratio

P/B ratio as of November 2024 : -6.51

According to Eterna Therapeutics's latest financial reports the company has a price-to-book ratio of 342.392.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Eterna Therapeutics - P/B ratio (from 2021 to 2024)

P/B ratio by year

Year P/B ratio Change
2024-12-31N/A-100%
2023-12-314.35218.94%
2022-12-311.36-83.98%
2021-12-318.51
2020-12-31N/A

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
2.24-134.42%๐Ÿ‡บ๐Ÿ‡ธ USA
8.21-226.21%๐Ÿ‡บ๐Ÿ‡ธ USA
-1.98-69.55%๐Ÿ‡บ๐Ÿ‡ธ USA
1.64-125.25%๐Ÿ‡ซ๐Ÿ‡ท France
5.53-184.98%๐Ÿ‡บ๐Ÿ‡ธ USA
3.04-146.80%๐Ÿ‡ฆ๐Ÿ‡บ Australia
3.06-146.98%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel